Over the past decade, antimicrobial blue light (aBL) at 400− 470 nm wavelength has
demonstrated immense promise as an alternative approach for the treatment of multidrug …

Antimicrobial blue light (aBL) therapy is a novel non-antibiotic antimicrobial approach which
works by generating reactive oxygen species. It has shown excellent antimicrobial ability to …

Continued efforts to reduce the risk of transfusion-transmitted infections (TTIs) through blood
and blood components led to the development of ultraviolet (UV) light irradiation …

In transfusion medicine, bacterial contamination can occur in ex vivo stored blood plasma,
and there are continued efforts to improve blood safety and reduce the risk of transfusion …

Despite significant advances in ensuring the safety of the blood supply, there is continued
risk of transfusion transmitted infections (TTIs) from newly emerging or re-emerging …

Chemical and UV light-based pathogen reduction technologies are currently in use for
human platelet concentrates (PCs) to enhance safety from transfusion-transmitted infections …

Violet–blue light of 405 nm in the visible spectrum at a dose of 270 J/cm2 alone has been
shown to be an effective microbicidal tool for inactivating several bacteria, HIV-1, and …

Chagas disease (ChD), caused by infection with the flagellated protozoan, Trypanosoma
cruzi, has a complicated transmission cycle with many infection routes. These include vector …

Fungal pathogens contribute to significant disease burden globally; however, the fact that
fungi are eukaryotes has greatly complicated their role in fungal-mediated infections and …

Added safety measures coupled with the development and use of pathogen reduction
technologies (PRT) significantly reduces the risk of transfusion-transmitted infections (TTIs) …